Ketones Group
These substances were identified for action under the Chemicals Management Plan (CMP). The assessment focused on 10 substances referred to collectively under the CMP as the Ketones Group.
| Substance group | CAS RN | Common name (acronym) | DSL name | Public comments on the draft screening assessment | Final assessment | Proposed risk management approach | Conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|---|---|---|---|
| Ketones Group | 78-93-3 | Methyl ethyl ketone (MEK) | 2-Butanone | HTML | HTML | HTML | Meets one or more of the criteria | Refer to proposed risk management approach |
| 107-87-9 | Methyl propyl ketone (MPK) | 2-Pentanone | None | Does not meet | None planned at this time | |||
| 108-10-1 | Methyl isobutyl ketone (MIBK) | 2-Pentanone, 4-methyl- | HTML | Meets one or more of the criteria | Refer to proposed risk management approach | |||
| 110-12-3 | Methyl isoamyl ketone (MIAK) | 2-Hexanone, 5-methyl | None | Does not meet | None planned at this time | |||
| 123-42-2 | Diacetone alcohol (DAA) | 2-Pentanone, 4-hydroxy-4-methyl- | ||||||
| 123-54-6 | 2,4-Pentanedione (2,4-PD) | 2,4-Pentanedione | None | Does not meet | Under consideration and proposed addition to the Watch List | |||
| 141-79-7 | Mesityl oxide (MO) | 3-Penten-2-one, 4-methyl- | None | Does not meet | None planned at this time | |||
| 431-03-8 | Diacetyl | 2,3-Butanedione | ||||||
| 513-86-0 | Acetoin | 2-Butanone, 3-hydroxy | ||||||
| 600-14-6 | 2,3-Pentanedione (2,3-PD) | 2,3-Pentanedione |
| Date | Activity |
|---|---|
| May 16, 2026 | Publication of the final assessment. The Proposed Risk Management Approach for Ketones, specifically: 2-Butanone (Methyl Ethyl Ketone; MEK) and 4-Methyl-2-pentanone (Methyl Isobutyl Ketone; MIBK) was also published for a 60-day public comment period. In addition, 2,4-PD is being proposed for addition to the Watch List. The related notice was published in the Canada Gazette, Part I: Vol. 160, No. 20. |
| June 24, 2023 | Publication in Canada Gazette, Part I, of a notice under section 71 of the Canadian Environmental Protection Act, 1999(CEPA). |
| January 19, 2019 | Publication and start of 60-day public comment period on the Draft Screening Assessment for the Ketones Group and the Risk Management Scope for Methyl Ethyl Ketone, Methyl Isobutyl Ketone, and 2,4-Pentanedione. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 3. |
Follow-up activities
Although 2,4-PD is not considered to be harmful to human health or to the environment at current levels of exposure, this substance is associated with effects of concern. Therefore, there may be a concern if exposures were to increase. For this reason, this substance may be considered in future initiatives to track its commercial status or identify new uses or exposures. In addition, this substance is being proposed for addition to the Watch List.
Watch List
The draft assessment for the Ketones Group was published on January 19, 2019, before the creation of the Watch List under CEPA. Therefore, 2,4-PD is proposed for addition to the Watch List based on the final assessment. Questions regarding this proposed addition can be submitted to:
Substances Management Information Line
Chemicals Management Plan
Environment and Climate Change Canada
Gatineau, Quebec K1A 0H3
Telephone: 1-800-567-1999 (in Canada) or 819-938-3232
Email: substances@ec.gc.ca
Information gathering
Section 71 CMP 2023
In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 – June 24, 2023 under section 71 of CEPA. This notice applies to MEK (CAS RN 78-93-3) and MIBK (CAS RN 108-10-1). More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.
Background
In the draft assessment, 2,4-PD was identified as a concern for human health based on its presence in a limited number of products available to consumers. Further investigation confirmed that 2,4-PD is not currently available in products available to consumers. Therefore, the final assessment concludes that 2,4-PD is not considered a concern for human health at current levels of exposure.